Biotech Finance Daily (DNDN)(MRK)(DNA)(BRCX)
Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company's news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke disappointed the ...Read Full Story »

